Lisy Wang

Long-term safety of tofacitinib for the treatment of rheumatoid arthritis up to 8.5 years: integrated analysis of data from the global clinical trials

Stanley Cohen, Yoshiya Tanaka, Xavier Mariette et al. · Annals of the Rheumatic Diseases · 2017 · 395 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Safety and efficacy of tofacitinib for up to 9.5 years in the treatment of rheumatoid arthritis: final results of a global, open-label, long-term extension study

J. Wollenhaupt, Eun-Bong Lee, Jeffrey R. Curtis et al. · Arthritis Research & Therapy · 2019 · 320 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +15

Tofacitinib for the treatment of ankylosing spondylitis: a phase III, randomised, double-blind, placebo-controlled study

Atul Deodhar, Paula Śliwińska-Stańczyk, Huji Xu et al. · Annals of the Rheumatic Diseases · 2021 · 248 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +10

Herpes Zoster and Tofacitinib: Clinical Outcomes and the Risk of Concomitant Therapy

Kevin Winthrop, Jeffrey R. Curtis, Stephen Lindsey et al. · Arthritis & Rheumatology · 2017 · 241 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +14

Long-term safety of tofacitinib up to 9.5 years: a comprehensive integrated analysis of the rheumatoid arthritis clinical development programme

Stanley Cohen, Yoshiya Tanaka, Xavier Mariette et al. · RMD Open · 2020 · 181 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17